Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Dividends Paid - Common: 2021-2024

Historic Dividends Paid - Common for Ani Pharmaceuticals (ANIP) over the last 4 years, with Dec 2024 value amounting to $1.6 million.

  • Ani Pharmaceuticals' Dividends Paid - Common fell 15.27% to $344,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 3.82%. This contributed to the annual value of $1.6 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2024, Ani Pharmaceuticals' Dividends Paid - Common is $1.6 million, which was down 0.00% from $1.6 million recorded in FY2023.
  • Ani Pharmaceuticals' 5-year Dividends Paid - Common high stood at $1.6 million for FY2022, and its period low was $190,000 during FY2021.
  • For the 3-year period, Ani Pharmaceuticals' Dividends Paid - Common averaged around $1.6 million, with its median value being $1.6 million (2024).
  • Data for Ani Pharmaceuticals' Dividends Paid - Common shows a peak YoY soared of 755.26% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Ani Pharmaceuticals' Dividends Paid - Common stood at $190,000 in 2021, then skyrocketed by 755.26% to $1.6 million in 2022, then remained steady at $1.6 million in 2023, then remained steady at $1.6 million in 2024.